BR112016029417A2 - desmopressina estabilizada - Google Patents

desmopressina estabilizada

Info

Publication number
BR112016029417A2
BR112016029417A2 BR112016029417A BR112016029417A BR112016029417A2 BR 112016029417 A2 BR112016029417 A2 BR 112016029417A2 BR 112016029417 A BR112016029417 A BR 112016029417A BR 112016029417 A BR112016029417 A BR 112016029417A BR 112016029417 A2 BR112016029417 A2 BR 112016029417A2
Authority
BR
Brazil
Prior art keywords
desmopressin
pharmaceutically acceptable
acceptable salt
active ingredient
pharmaceutical composition
Prior art date
Application number
BR112016029417A
Other languages
English (en)
Other versions
BR112016029417A8 (pt
Inventor
Sang Lee Bong
Han Jiyeong
Seop Kim Min
Kil Myeongcheol
Park Su-Jun
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53510836&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112016029417(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of BR112016029417A2 publication Critical patent/BR112016029417A2/pt
Publication of BR112016029417A8 publication Critical patent/BR112016029417A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Abstract

a presente invenção refere-se a uma composição farmacêutica compreendendo um ingrediente ativo e um agente estabilizante, em que o ingrediente ativo é desmopressina ou um sal farmaceuticamente aceitável do mesmo e em que o agente estabilizante é pelo menos uma goma, a utilização de uma ou mais gomas para aumentar a estabilidade de uma composição farmacêutica compreendendo desmopressina ou um sal aceitável do mesmo sob o ponto de vista farmacêutico como um ingrediente ativo contra a desnaturação, um método para preparar uma película de desintegração oral compreendendo desmopressina ou um sal farmaceuticamente aceitável do mesmo bem como uma película de desintegração oral que pode ser obtida por meio desta.
BR112016029417A 2014-06-16 2015-06-15 composição farmacêutica que compreende desmopressina, uso de uma ou mais gomas para aumentar sua estabilidade, película de desintegração oral e seu método de preparação BR112016029417A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020140073067A KR20150144209A (ko) 2014-06-16 2014-06-16 안정화된 데스모프레신 또는 이의 약학적으로 허용가능한 염을 함유 약학 조성물
PCT/EP2015/063347 WO2015193246A1 (en) 2014-06-16 2015-06-15 Stabilized desmopressin

Publications (2)

Publication Number Publication Date
BR112016029417A2 true BR112016029417A2 (pt) 2017-08-22
BR112016029417A8 BR112016029417A8 (pt) 2021-06-29

Family

ID=53510836

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112016029417A BR112016029417A8 (pt) 2014-06-16 2015-06-15 composição farmacêutica que compreende desmopressina, uso de uma ou mais gomas para aumentar sua estabilidade, película de desintegração oral e seu método de preparação

Country Status (34)

Country Link
US (1) US20170128521A1 (pt)
EP (1) EP3154516B1 (pt)
JP (1) JP6615130B2 (pt)
KR (2) KR20150144209A (pt)
CN (1) CN106456706B (pt)
AR (1) AR100850A1 (pt)
AU (1) AU2015276247C1 (pt)
BR (1) BR112016029417A8 (pt)
CA (1) CA2951768C (pt)
CL (1) CL2016003219A1 (pt)
CO (1) CO2017000354A2 (pt)
DK (1) DK3154516T3 (pt)
EA (1) EA032834B1 (pt)
ES (1) ES2751600T3 (pt)
HR (1) HRP20191746T1 (pt)
HU (1) HUE045395T2 (pt)
IL (1) IL249538A0 (pt)
JO (1) JO3500B1 (pt)
LT (1) LT3154516T (pt)
MX (1) MX2016016635A (pt)
MY (1) MY182781A (pt)
NZ (1) NZ727388A (pt)
PH (1) PH12016502527B1 (pt)
PL (1) PL3154516T3 (pt)
PT (1) PT3154516T (pt)
RS (1) RS59449B1 (pt)
SA (1) SA516380492B1 (pt)
SG (2) SG11201609374YA (pt)
SI (1) SI3154516T1 (pt)
TN (1) TN2016000561A1 (pt)
TW (1) TWI670070B (pt)
UA (1) UA119776C2 (pt)
WO (1) WO2015193246A1 (pt)
ZA (1) ZA201608020B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114432424B (zh) * 2021-12-27 2023-06-27 南通联亚药业股份有限公司 一种稳定的铝塑包装去氨加压素片剂

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE60941B1 (en) * 1986-07-10 1994-09-07 Elan Transdermal Ltd Transdermal drug delivery device
GB0210397D0 (en) * 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
WO2003094886A2 (en) * 2002-05-07 2003-11-20 Ferring Bv Desmopressin in an orodispersible dosage form
WO2007083323A2 (en) * 2006-01-23 2007-07-26 Panacea Biotec Limited. Modified release oral dosage form comprising desmopressin
CN100463674C (zh) * 2006-12-22 2009-02-25 江苏奥赛康药业有限公司 一种氯雷他定口腔速溶膜及其制备方法
US20150306170A1 (en) * 2012-11-21 2015-10-29 Ferring B.V. Composition for immediate and extended release
TW201422254A (zh) * 2012-11-21 2014-06-16 Ferring Bv 用於速釋及延釋的組成物

Also Published As

Publication number Publication date
PH12016502527A1 (en) 2017-04-10
LT3154516T (lt) 2019-10-25
CL2016003219A1 (es) 2017-06-30
RS59449B1 (sr) 2019-11-29
JP2017523955A (ja) 2017-08-24
CN106456706B (zh) 2020-07-14
DK3154516T3 (da) 2019-09-23
CN106456706A (zh) 2017-02-22
HUE045395T2 (hu) 2019-12-30
PT3154516T (pt) 2019-12-05
HRP20191746T1 (hr) 2019-12-27
KR20150144209A (ko) 2015-12-24
EA201692556A1 (ru) 2017-04-28
KR20170020450A (ko) 2017-02-22
ES2751600T3 (es) 2020-04-01
PH12016502527B1 (en) 2017-04-10
MX2016016635A (es) 2017-06-06
SI3154516T1 (sl) 2019-11-29
AU2015276247C1 (en) 2020-02-06
AR100850A1 (es) 2016-11-02
UA119776C2 (uk) 2019-08-12
EP3154516B1 (en) 2019-09-04
AU2015276247B2 (en) 2019-09-12
SA516380492B1 (ar) 2021-02-03
AU2015276247A1 (en) 2017-02-02
TWI670070B (zh) 2019-09-01
PL3154516T3 (pl) 2020-08-10
EP3154516A1 (en) 2017-04-19
TN2016000561A1 (en) 2018-04-04
ZA201608020B (en) 2020-05-27
EA032834B1 (ru) 2019-07-31
SG10201811139UA (en) 2019-01-30
CO2017000354A2 (es) 2017-03-31
NZ727388A (en) 2021-07-30
TW201605464A (zh) 2016-02-16
KR102360656B1 (ko) 2022-02-09
CA2951768A1 (en) 2015-12-23
IL249538A0 (en) 2017-02-28
WO2015193246A1 (en) 2015-12-23
SG11201609374YA (en) 2017-01-27
CA2951768C (en) 2022-08-30
JO3500B1 (ar) 2020-07-05
BR112016029417A8 (pt) 2021-06-29
JP6615130B2 (ja) 2019-12-04
MY182781A (en) 2021-02-05
US20170128521A1 (en) 2017-05-11

Similar Documents

Publication Publication Date Title
BR122021018243A8 (pt) Composição tópica de baixo ph e método para aumentar a aplicação tópica de um ingrediente ativo cosmeticamente aceitável
CL2017001488A1 (es) Benzamidas sustituidas con 1,3–tiazol–2–ilo
DOP2016000156A (es) Composiciones farmacã¿uticas que comprenden azd9291.
DOP2016000253A (es) Nuevos compuestos
CL2017003066A1 (es) Composiciones de carbonato de calcio amorfo para administración mediante inhalación, sublingual o bucal
BR112017004798A2 (pt) composição farmacêutica que contém um derivado de ácido hidroxâmico ou um seu sal
EA201691600A1 (ru) Дигидропиридиноновые ингибиторы mgat2 для применения в лечении метаболических нарушений
BR112017028468A2 (pt) formulação sólida oral, e método para preparar uma formulação sólida oral
BR112017014361A2 (pt) métodos para aperfeiçoamento de terapia celular
BR112018001035A2 (pt) compostos de fenoxiacetamidas aneladas, sal farmaceuticamente aceitável, seu método de síntese, combinação de medicamento e uso dos mesmos
BR112016026552A8 (pt) derivados de carboxamida, seus usos, composição farmacêutica, e combinação
DOP2016000251A (es) Inhibidores de las vías de señalización de wnt
CL2016000884A1 (es) Derivados de piperazina y su uso como medicamento.
AR106559A1 (es) Suspensión acuosa para administración oral y método para su preparación
BR112017024126B8 (pt) Composições farmacêuticas, composto a micronizado e/ou pelo menos um sal farmaceuticamente aceitável micronizado do composto a e uso dos mesmos
BR112016029417A2 (pt) desmopressina estabilizada
CO2017004382A2 (es) Composiciones farmacéuticas que comprenden lobeglitazona para administración oral
EA201992844A1 (ru) Новые пероральные составы на основе белиностата
EA201890477A1 (ru) Инкапсулированная композиция финголимода
EA201891848A1 (ru) Фармацевтическая композиция для применения в лечении фиброза
BR112018002138A2 (pt) composto 2-(5 s-metil-2-oxo-4r-fenil-pirrolidin-1-il)-acetamida, uso, composição farmacêutica e método para a profilaxia ou o tratamento de convulsões
AR106415A1 (es) Composición farmacéutica para el tratamiento del dolor
EA201200799A1 (ru) Гепатопротекторное средство
BR112016024918A2 (pt) ?uso de uma droga?
BR112019002799A2 (pt) composto, composição farmacêutica, método para tratar um indivíduo tendo uma doença neurodegenerativa, método para tratar um indivíduo tendo a doença de alzheimer e método para tratar um indivíduo tendo uma doença ou condição

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09S Decision of refusal: publication cancelled [chapter 9.2.2 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 9.2 NA RPI NO 2702 DE 18/10/2022 POR TER SIDO INDEVIDA.

B06A Patent application procedure suspended [chapter 6.1 patent gazette]